XOMA Corp (XOMA)

5.52
0.01 0.18
NASDAQ : Health Care
Prev Close 5.53
Open 5.52
Day Low/High 5.52 / 5.52
52 Wk Low/High 0.44 / 2.03
Volume 357.00
Avg Volume 79.30K
Exchange NASDAQ
Shares Outstanding 6.05M
Market Cap 34.77M
EPS -3.40
Div & Yield N.A. (N.A)

Latest News

XOMA Reaches Analyst Target Price

XOMA Reaches Analyst Target Price

In recent trading, shares of XOMA Corp have crossed above the average analyst 12-month target price of $1.09, changing hands for $6.24/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

XOMA Announces Significant Step Toward Initiating Pediatric Phase 2 Clinical Study For XOMA 358 In Children With Congenital Hyperinsulinism

XOMA Announces Significant Step Toward Initiating Pediatric Phase 2 Clinical Study For XOMA 358 In Children With Congenital Hyperinsulinism

Company Reached Agreement with MHRA on General Trial Design for Multi-dose Testing in Children 2 Years and Older in the United Kingdom

XOMA Announces Reverse Stock Split

XOMA Announces Reverse Stock Split

XOMA Initiates XOMA 358 Proof-of-Concept Study In Patients With Hypoglycemia Post Gastric Bypass Surgery

XOMA Initiates XOMA 358 Proof-of-Concept Study In Patients With Hypoglycemia Post Gastric Bypass Surgery

Novel first-in-class antibody enters clinic for second rare hypoglycemic indication

XOMA Presented First Data From Novel Antibody Fragment To Address Severe Acute Hypoglycemia At The ENDO Meeting

XOMA Presented First Data From Novel Antibody Fragment To Address Severe Acute Hypoglycemia At The ENDO Meeting

Data supports continued development of XOMA 129 as a novel targeted therapy for the treatment of hypoglycemic conditions

XOMA (XOMA) Weak On High Volume

XOMA (XOMA) Weak On High Volume

Trade-Ideas LLC identified XOMA (XOMA) as a weak on high relative volume candidate

Xoma Stock Soaring on Q4 Earnings Beat

Xoma Stock Soaring on Q4 Earnings Beat

Xoma stock is gaining on heavy trading volume early Thursday afternoon after the company reported its 2015 fourth quarter results after yesterday’s closing bell.

Xoma Stock Surges in After-Hours Trading on Q4 Results

Xoma Stock Surges in After-Hours Trading on Q4 Results

Xoma stock is jumping in after-hours trading on Wednesday after the company reported its 2015 fourth quarter results.

XOMA Reports Fourth Quarter And Full-Year 2015 Financial Results

XOMA Reports Fourth Quarter And Full-Year 2015 Financial Results

Company Advancing Its Endocrine Portfolio After Completing Divestiture of Non-Core Assets

Friday Small-Cap Focus: Xoma

Small biotech plunged in July, but has stabilized on two key deals.

Xoma Stock Surges, Sells Diabetes Treatment to Novo Nordisk for $295 Million

Xoma Stock Surges, Sells Diabetes Treatment to Novo Nordisk for $295 Million

Xoma stock is rising in early afternoon trading on Tuesday after Novo Nordisk bought its diabetes treatment for $295 million.

Strong On High Volume: XOMA (XOMA)

Strong On High Volume: XOMA (XOMA)

Trade-Ideas LLC identified XOMA (XOMA) as a strong on high relative volume candidate

XOMA Announces The Sale Of Its Manufacturing Facilities To Agenus

XOMA Announces The Sale Of Its Manufacturing Facilities To Agenus

XOMA's divests biodefense program to Nanotherapeutics, Inc.